UniProt ID | FLOT1_HUMAN | |
---|---|---|
UniProt AC | O75955 | |
Protein Name | Flotillin-1 | |
Gene Name | FLOT1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 427 | |
Subcellular Localization |
Cell membrane Peripheral membrane protein . Endosome . Membrane, caveola Peripheral membrane protein . Melanosome . Membrane raft . Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). Membrane-associ |
|
Protein Description | May act as a scaffolding protein within caveolar membranes, functionally participating in formation of caveolae or caveolae-like vesicles.. | |
Protein Sequence | MFFTCGPNEAMVVSGFCRSPPVMVAGGRVFVLPCIQQIQRISLNTLTLNVKSEKVYTRHGVPISVTGIAQVKIQGQNKEMLAAACQMFLGKTEAEIAHIALETLEGHQRAIMAHMTVEEIYKDRQKFSEQVFKVASSDLVNMGISVVSYTLKDIHDDQDYLHSLGKARTAQVQKDARIGEAEAKRDAGIREAKAKQEKVSAQYLSEIEMAKAQRDYELKKAAYDIEVNTRRAQADLAYQLQVAKTKQQIEEQRVQVQVVERAQQVAVQEQEIARREKELEARVRKPAEAERYKLERLAEAEKSQLIMQAEAEAASVRMRGEAEAFAIGARARAEAEQMAKKAEAFQLYQEAAQLDMLLEKLPQVAEEISGPLTSANKITLVSSGSGTMGAAKVTGEVLDILTRLPESVERLTGVSISQVNHKPLRTA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MFFTCGPNEAM ----CCCCCCCCCEE | 12.80 | 24719451 | |
19 | Phosphorylation | VVSGFCRSPPVMVAG EEECCCCCCCEEEEC | 34.43 | 23911959 | |
23 | Sulfoxidation | FCRSPPVMVAGGRVF CCCCCCEEEECCEEE | 1.79 | 28465586 | |
34 | S-palmitoylation | GRVFVLPCIQQIQRI CEEEEEHHHHHHHHC | 3.71 | 29575903 | |
51 | Ubiquitination | NTLTLNVKSEKVYTR CCEEEEECCCEEEEC | 52.39 | 21890473 | |
51 | Acetylation | NTLTLNVKSEKVYTR CCEEEEECCCEEEEC | 52.39 | 26051181 | |
51 | Ubiquitination | NTLTLNVKSEKVYTR CCEEEEECCCEEEEC | 52.39 | 21890473 | |
56 | Phosphorylation | NVKSEKVYTRHGVPI EECCCEEEECCCCEE | 14.77 | - | |
78 | Ubiquitination | VKIQGQNKEMLAAAC EEECCCCHHHHHHHH | 36.29 | - | |
128 | Phosphorylation | YKDRQKFSEQVFKVA HHCHHHHHHHHHHHH | 33.87 | 20068231 | |
136 | Phosphorylation | EQVFKVASSDLVNMG HHHHHHHHHHHHHCC | 27.63 | 28851738 | |
137 | Phosphorylation | QVFKVASSDLVNMGI HHHHHHHHHHHHCCE | 25.81 | 28851738 | |
145 | Phosphorylation | DLVNMGISVVSYTLK HHHHCCEEEEEEECC | 15.67 | 24260401 | |
148 | Phosphorylation | NMGISVVSYTLKDIH HCCEEEEEEECCCCC | 15.39 | 28851738 | |
149 | Phosphorylation | MGISVVSYTLKDIHD CCEEEEEEECCCCCC | 12.41 | - | |
150 | Phosphorylation | GISVVSYTLKDIHDD CEEEEEEECCCCCCC | 21.59 | 28851738 | |
160 | Phosphorylation | DIHDDQDYLHSLGKA CCCCCCHHHHHCCCH | 10.73 | 27794612 | |
163 | Phosphorylation | DDQDYLHSLGKARTA CCCHHHHHCCCHHCH | 35.90 | 26055452 | |
166 | Malonylation | DYLHSLGKARTAQVQ HHHHHCCCHHCHHHH | 39.73 | 26320211 | |
166 | Ubiquitination | DYLHSLGKARTAQVQ HHHHHCCCHHCHHHH | 39.73 | - | |
169 | Phosphorylation | HSLGKARTAQVQKDA HHCCCHHCHHHHHHH | 26.71 | 23532336 | |
195 | Ubiquitination | GIREAKAKQEKVSAQ CHHHHHHHHHHHCHH | 59.28 | - | |
200 | Phosphorylation | KAKQEKVSAQYLSEI HHHHHHHCHHHHHHH | 22.26 | 21945579 | |
203 | Phosphorylation | QEKVSAQYLSEIEMA HHHHCHHHHHHHHHH | 16.35 | 21945579 | |
205 | Phosphorylation | KVSAQYLSEIEMAKA HHCHHHHHHHHHHHH | 31.43 | 21945579 | |
211 | Ubiquitination | LSEIEMAKAQRDYEL HHHHHHHHHHCCHHH | 43.68 | - | |
216 | Phosphorylation | MAKAQRDYELKKAAY HHHHHCCHHHHHHHH | 25.91 | - | |
220 | Methylation | QRDYELKKAAYDIEV HCCHHHHHHHHCCCC | 51.37 | - | |
223 | Phosphorylation | YELKKAAYDIEVNTR HHHHHHHHCCCCCCH | 23.47 | 25884760 | |
238 | Phosphorylation | RAQADLAYQLQVAKT HHHHHHHHHHHHHHH | 19.63 | 21945579 | |
292 | Phosphorylation | KPAEAERYKLERLAE CHHHHHHHHHHHHHH | 16.07 | - | |
302 | Ubiquitination | ERLAEAEKSQLIMQA HHHHHHHHHHHHHHH | 51.02 | - | |
303 | Phosphorylation | RLAEAEKSQLIMQAE HHHHHHHHHHHHHHH | 23.02 | 20068231 | |
315 | Phosphorylation | QAEAEAASVRMRGEA HHHHHHHHHHHHHHH | 19.80 | 21399631 | |
348 | Phosphorylation | KAEAFQLYQEAAQLD HHHHHHHHHHHHHHH | 8.10 | 27259358 | |
374 | Ubiquitination | EISGPLTSANKITLV HHCCCCCCCCEEEEE | 37.21 | 21890473 | |
379 | Phosphorylation | LTSANKITLVSSGSG CCCCCEEEEEECCCC | 23.79 | 20068231 | |
382 | Phosphorylation | ANKITLVSSGSGTMG CCEEEEEECCCCCCC | 31.90 | 29255136 | |
383 | Phosphorylation | NKITLVSSGSGTMGA CEEEEEECCCCCCCC | 29.51 | 29255136 | |
385 | Phosphorylation | ITLVSSGSGTMGAAK EEEEECCCCCCCCHH | 32.79 | 29255136 | |
387 | Phosphorylation | LVSSGSGTMGAAKVT EEECCCCCCCCHHHH | 17.71 | 29255136 | |
392 | Ubiquitination | SGTMGAAKVTGEVLD CCCCCCHHHHHHHHH | 39.53 | - | |
402 | Phosphorylation | GEVLDILTRLPESVE HHHHHHHHCCCHHHH | 30.41 | 28102081 | |
407 | Phosphorylation | ILTRLPESVERLTGV HHHCCCHHHHHHHCC | 27.60 | 20068231 | |
422 | Ubiquitination | SISQVNHKPLRTA-- CHHHCCCCCCCCC-- | 40.31 | 21890473 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FLOT1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FLOT1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-387, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-203, AND MASSSPECTROMETRY. |